Clinical Trial

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2022-12-12; most recent amendment 2026-02-06.
Status change: Not Yet Recruiting → Recruiting 2023-04-04
Trial Details
NCT Number NCT05657990
Lead Sponsor Hackensack Meridian Health
Conditions Urinary Retention
Enrollment 46 participants
Start Date 2023-04-03
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-10